Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Recruiting1
Other1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT06760156Phase 2Recruiting
Tafasitamab and Lenalidomide as First Salvage Therapy for Residual Large B Cell Lym
Large B-cell Lymphoma
PrincipalinvestigatorStart date: 2025-03-19
NCT04745559Phase 2Active Not Recruiting
Optimizing Cellular and Humoral Immunity by Vaccinating With PCV13 Before and After CAR-T Therapy
Diffuse Large-Cell LymphomaFollicular LymphomaHigh-grade B-cell Lymphoma (HGBCL)+2 more
PrincipalinvestigatorStart date: 2021-02-18

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jae Park, MD

Memorial Sloan Kettering Cancer Center

Related
17 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseLarge B-cell Lymphoma

Worked with same sponsors:

Incyte Corporation
Similarity Score10%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Lymphoma, FollicularLymphoma, Large B-Cell, Diffuse
Similarity Score10%

Weili Zhao

Ruijin Hospital

Related
11 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseLymphoma, Follicular
Similarity Score10%

William Wegener, MD, PhD

Gilead Sciences

Related
12 trials

Shared therapeutic areas:

Lymphoma, FollicularLymphoma, Large B-Cell, Diffuse
Similarity Score10%

Hongmei Jing

Peking University Third Hospital

Related
4 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseLarge B-cell Lymphoma
Similarity Score10%

Roberto Hernández Martín, MD

Hospital Virgen de la Concha

Related
2 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, Diffuse
Similarity Score5%

Elena Pérez Ceballos, MD

Hospital Morales Meseguer

Related
2 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, Diffuse
Similarity Score5%

Hagop Youssoufian, MD

Verastem, Inc.

Related
20 trials

Shared therapeutic areas:

Lymphoma, Follicular
Similarity Score5%

Qifa Liu

Nanfang Hospital, Southern Medical University

Related
33 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, Diffuse
Similarity Score5%

Sarit Assouline, MD

Jewish General Hospital

Related
5 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, Diffuse
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT06760156Phase 2PrincipalInvestigator

Tafasitamab and Lenalidomide as First Salvage Therapy for Residual Large B Cell Lym

Large B-cell Lymphoma
Recruiting
NCT04745559Phase 2PrincipalInvestigator

Optimizing Cellular and Humoral Immunity by Vaccinating With PCV13 Before and After CAR-T Therapy

Diffuse Large-Cell LymphomaFollicular LymphomaHigh-grade B-cell Lymphoma (HGBCL)+2 more
Active Not Recruiting

All 2 trials loaded